Press Enter to search · Esc to close
A seven-marker aging clock built on nearly 60,000 blood samples and machine-learning screens for natural geroprotectors hint at a clinic-ready future for longevity medicine — with caveats.
A new systematic review pools 17 plasma proteomics datasets into a shortlist of candidate proteins — the scaffolding for a next-generation aging clock that may one day rival DNA methylation.
A new clinical clock called LinAge2 is trained to predict survival, not just guess your age — a quiet but meaningful shift for anyone paying for an epigenetic age test.